A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment.
Ertam
Ilgen
I
Sezgin
Aycan Ozden
AO
Unal
Idil
I
D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D002675:Child, Preschool; D000078306:Clobazam; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D018570:Risk Assessment; D012640:Seizures / Q000175:diagnosis / Q000188:drug therapy*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome; D014227:Triazines / Q000009:adverse effects / Q000627:therapeutic use; D014635:Valproic Acid / Q000009:adverse effects / Q000627:therapeutic use
D000927:Anticonvulsants; D014227:Triazines; D001569:Benzodiazepines; D000078306:Clobazam; D014635:Valproic Acid; D011239:Prednisolone; D000077213:Lamotrigine